Results 221 to 230 of about 46,160 (296)

Trends in Atypical Antipsychotic Use Among Children and Adolescents With Depressive Disorders in Korea. [PDF]

J Korean Med Sci
Park KJ, Kim YJ, Jung E, Kim JY, Moon DS, Park J, Lee MS, Kim HW.   +7 more
europepmc   +1 more source

Self‐help group participation, avoidance of nonalcoholic beer, and nonsmoking independently predict better drinking outcomes in Japanese alcohol‐dependent men

Alcohol, Clinical and Experimental Research, Volume 50, Issue 2, February 2026.
This prospective study of 198 Japanese men found that one‐year abstinence after inpatient alcohol treatment was significantly higher among those who joined self‐help groups, avoided nonalcoholic beer, and did not resume smoking. A clear dose–response pattern showed that combining all three behaviors offered the strongest protection against relapse ...
Akira Yokoyama, Mitsuru Kimura, Atsushi Yoshimura, Junichi Yoneda, Hitoshi Maesato, Yasunobu Komoto, Hideki Nakayama, Hiroshi Sakuma, Yosuke Yumoto, Tsuyoshi Takimura, Tomomi Toyama, Takeshi Mizukami, Tetsuji Yokoyama, Susumu Higuchi, Sachio Matsushita   +14 more
wiley   +1 more source

Add-On Pharmacotherapy in Schizophrenia: Does It Improve Long-Term Outcomes? A Systematic Review. [PDF]

J Clin Med
Smyrnis A, Smyrnis G, Smyrnis N.
europepmc   +1 more source

Association Between Metabolic Syndrome, Obesity, and Cognitive Performances in Individuals With Bipolar Disorders: Cross‐Sectional and Longitudinal Analyses in the FACE‐BD Cohort

Acta Psychiatrica Scandinavica, Volume 153, Issue 2, Page 108-121, February 2026.
ABSTRACT Introduction Metabolic syndrome (MetS) has been suggested to be associated with cognitive impairments in bipolar disorder (BD); however, studies are limited by small sample sizes or cross‐sectional design. Our objective is to evaluate the cross‐sectional and longitudinal associations between MetS and cognitive performances in a large cohort of
I. Palimaru, B. Etain, M. Leboyer, Y. Dansou, P. Favre, S. Gard, V. Aubin, F. Bellivier, R. Belzeaux, P. Courtet, C. Dubertret, E. Haffen, A. Lefrere, P. M. Llorca, E. Olié, M. Polosan, L. Samalin, R. Schwan, the FondaMental Academic Centers of Expertise in Bipolar Disorders (FACE‐BD) Collaborators, B. Etain, E. Olié, M. Leboyer, E. Haffen, P. M. Llorca, V. Barteau, S. Bensalem, O. Godin, H. Laouamri, K. Souryis, S. Hotier, A. Pelletier, F. Hergeta, J. Petrucci, L. Willaume, F. Bellivier, B. Etain, V. Hennion, E. Marlinge, J. Meheust, A. Richard, M. Carminati, H. Francisque, S. Gard, K. M’Bailara, C. Elkael, F. Hoorelbeke, I. Minois, J. Sportich, N. Da Ros, C. Dubertret, N. Mazer, C. Portalier, C. Scognamiglio, A. Bing, P. Laurent, L. Boukhobza, P. Courtet, S. Denat, B. Deffinis, D. Ducasse, M. Gachet, A. Lengvenyté, F. Molière, L. Nass, E. Olié, G. Tarquini, A. Lefrere, E. Moreau, J. Pastol, F. Groppi, H. Polomeni, J. Bauberg, L. Lescalier, I. Muraccioli, A. Suray, R. Cohen, J. P. Kahn, M. Milazzo, O. Wajsbrot‐Elgrabli, T. Bougerol, A. Pouchon, A. Bertrand, B. Fredembach, A. Suisse, Q. Denoual, M. Polosan, A. M. Galliot, L. Brehon, G. Bonny, L. Durand, V. Feuga, N. Kayser, P. Roux, V. Aubin, I. Cussac, M. A. Dupont, J. Loftus, I. Medecin, C. Dubertret, N. Mazer, P. Laurent, L. Samalin, P. M. Llorca, M. Mennetrier, T. Bonnet, D. Lacelle, M. Vayssié, C. Beal, O. Blanc, P. Roux, O. Godin   +110 more
wiley   +1 more source

Three years of medication-use sequences in incident bipolar disorder in Sweden reveal divergent patterns in native-born and immigrant populations. [PDF]

Transl Psychiatry
Kautzky A, Gémes K, Ármannsdóttir B, Amin R, Akhtar A, Lieslehto J, Tanskanen A, Taipale H, Mittendorfer-Rutz E.   +8 more
europepmc   +1 more source

Effects of Intravenous Ketamine on Posttraumatic Stress Disorder (PTSD): A Systematic Review

Acta Psychiatrica Scandinavica, Volume 153, Issue 2, Page 95-107, February 2026.
ABSTRACT Introduction Posttraumatic stress disorder (PTSD) is a mental disorder resulting from exposure to traumatic events. Evidence suggests that ketamine may be efficacious in treating PTSD, however, ketamine's mechanisms in treating PTSD remain unclear. Herein, this review aims to evaluate the clinical outcomes of ketamine treatment in persons with
Liyang Yin, Andy Lu, Gia Han Le, Christine E. Dri, Sabrina Wong, Kayla M. Teopiz, Heidi Xu, Roger Ho, Taeho Greg Rhee, Heidi Ka Ying Lo, Maria‐Christina Sioufi, Yang Jing Zheng, Hezekiah C. T. Au, Hernan F. Guillen‐Burgos, Bing Cao, Roger S. McIntyre   +15 more
wiley   +1 more source

Association of Atypical Antipsychotics With Lipid Abnormalities in Adult Patients With Schizophrenia: A Scoping Review. [PDF]

Neuropsychopharmacol Rep
Abavana V, Sadiq S.
europepmc   +1 more source

Knowledge and Confidence in Psychotropic Prescribing, Utilisation of Guidelines and Resources in Managing Perinatal Mental Health in General Practice: An Australian Cross‐Sectional Survey

Australian Journal of Rural Health, Volume 34, Issue 1, February 2026.
ABSTRACT Objective Management of psychiatric disorders in the perinatal period is a common presentation in primary care. There is a need to understand how general practitioners (GPs) use guidelines and resources and incorporate the knowledge within clinical practice.
Jacqueline Frayne, Sarah Seddon, Tamara Lebedevs, Talila Milroy, Beverly Teh, Thinh Nguyen   +5 more
wiley   +1 more source

Reporting Frequency of Antipsychotics-Induced Tardive Dyskinesia and Other Extrapyramidal Symptoms: Analysis Based on a Spontaneous Reporting System Database in Japan. [PDF]

Neuropsychopharmacol Rep
Saga Y, Horio H, Chiang CL, Wakamatsu A.
europepmc   +1 more source

A Clinical Medication Review Focused on Deprescribing in Older Patients With Hyperpolypharmacy: A Mixed‐Methods Feasibility Study

Basic &Clinical Pharmacology &Toxicology, Volume 138, Issue 2, February 2026.
ABSTRACT To address challenges in deprescribing, we investigated the feasibility of an intervention consisting of a clinical medication review (CMR) focused on deprescribing, supported by a training programme for healthcare providers (HCPs) among older patients with hyperpolypharmacy (≥ 10 chronic medications) in primary care.
Gert Baas, Mette Heringa, Sanne Verdoorn, Henk‐Frans Kwint, Eman Badawy, Jacobijn Gussekloo, Marcel Bouvy   +6 more
wiley   +1 more source